New Horizons in Care: Finding Hope in Second-Line SCC Treatment

Explore treatment considerations after recurrent or metastatic SCC, including questions about side effects, testing and clinical trials.

0 Shares

For people facing recurrent or metastatic head and neck SCC, the next step means a new plan with their care team. That plan will depend on where the cancer is, what treatment a person has already received and what matters most to them. Research is also exploring new approaches, giving patients more questions to bring to those conversations.

This set of circumstances is not at all uncommon. James, a participant in our 30 Stories campaign, shared his story offering one perspective on what can happen when aggressive head and neck squamous cell carcinoma spreads. After his cancer recurred and spread to his hips, kidneys and lungs, he began immunotherapy. He shares how treatment affected his daily life and how his family helped him through an uncertain time.

What Recurrent or Metastatic SCC Means

“Recurrent” means the cancer has returned after treatment. “Metastatic” means it has spread from where it first began to another part of the body. These terms describe what has happened to the cancer. They do not, by themselves, explain which treatment is right for an individual.

Head and neck SCC can begin in areas such as the mouth, throat or voice box. This article focuses on recurrent or metastatic SCC. The cancer’s original location, test results and treatment history all matter, so a person’s care plan may differ from someone else’s even when both were originally diagnosed with SCC.

How the Care Team Checks for a Recurrence

If symptoms, an exam or imaging raise concern, the care team may recommend further tests to understand what has changed. This could include imaging, a physical examination or review of a tissue sample. The tests depend on the individual situation. Patients should ask what each test is meant to clarify and when they can expect results.

A suspected recurrence can also prompt a review of earlier pathology and treatment records. The team may look at how the cancer responded, how long it was controlled and whether the new findings change the treatment discussion. For patients, it is recommended to bring a list of prior treatments and questions to the appointment.

How the Next SCC Treatment Plan Takes Shape

The oncology team may consider the cancer’s location and extent of spread, any previous surgeries or radiation treatments, chemotherapy or other agents, any current symptoms and the patient’s overall health. As the new plan unfolds, foremost are the patient’s priorities, including what they hope treatment will do and what side effects they most want to avoid.

Review What Previous Treatment Has Taught the Team

The way cancer responded to an earlier treatment may affect what clinicians consider next. The time between treatment and the recurrence can also be part of the discussion. These details do not determine the plan on their own, but they help the care team explain why some approaches may be considered and others may not fit.

Patients can ask the team to explain how their past treatment affects their current options. If the plan feels complicated, it is always reasonable to ask for the choices to be explained again, in plain language, or to bring a trusted person to take notes.

Ask Whether Testing Could Help Guide Decisions

A tumor may have features that help the care team consider treatment options. These are called biomarkers. Depending on the cancer and the treatments being discussed, the team may review earlier test results or recommend additional testing. Testing is not useful in every situation, and a result cannot guarantee that a treatment will work.

If your cancer has returned or spread, ask your care team whether any tumor or biomarker testing could help guide your next treatment decision. 

Questions to Ask About Biomarker Testing

  • Have my tumor’s features already been tested?
  • Could testing help identify treatment options or a clinical trial?
  • Would a new biopsy be needed, and what would it involve?
  • When will we get the results, and could they affect when treatment starts?

Consider bringing a family member or caregiver to help take notes. Testing recommendations vary by cancer type and treatment history, so ask your oncology team what applies to your situation. ASCO provides guidance on biomarker testing and immunotherapy for recurrent and metastatic head and neck cancers.

Doctor and patient are talking at treament

What “Second-Line Treatment” Means for SCC

“Second-line treatment” generally refers to treatment considered after an earlier treatment has stopped controlling the cancer, or after the cancer has returned or progressed. It describes where an option falls in the treatment sequence. It does not name one medicine or plan that is right for everyone.

Depending on the situation, the care team may discuss systemic treatment, a local treatment for a particular area or a clinical trial. The most appropriate options depend on factors such as cancer location, previous treatment, test results, symptoms and the patient’s goals. A patient’s oncologist can explain which options apply to their case.

Consider the Goals & Tradeoffs of Each Option

Before making a decision, patients can and should ask what the proposed treatment is intended to do. The goal may be to control the cancer, slow its growth or address a symptom. Patients can also ask about likely side effects, how treatment may fit into daily life and how the team will assess whether it is helping.

A practical way to compare options is for the patient to write down what matters most. For one person, that may be managing a symptom. For another, it may be treatment time, travel or keeping up with daily responsibilities. There is no single priority patients are expected to have. But it is important for the care team to know what matters to the person receiving care.

Questions to Bring to a Treatment Discussion

  • What is the goal of this option?
  • How does my previous treatment affect what I can consider now?
  • What side effects should I know about?
  • How will we know whether treatment is helping?
  • What happens if this approach does not work for me?
  • Does this approach exclude me from other possible treatment paths?

Find more stories like yours!

Explore the journey of other survivors and caregivers on the 30 Stories podcast and blog.

New Research Offers Questions Worth Asking

Research is testing new ways to treat recurrent or metastatic head and neck SCC. Some approaches are available only through clinical trials. A clinical trial is a research study designed to answer questions about a treatment or care approach. Taking part is a personal choice, and eligibility depends on the study’s requirements and a person’s circumstances.

Ask About Clinical Trials Early

It can be useful to ask about clinical trials while discussing the next treatment plan. A trial could be an option now, it may not be a fit or it may become relevant later. Clinical trial availability can change, and a study’s eligibility rules can be very specific. So it’s important to remember that an online search result alone cannot determine whether someone qualifies.

Patients can ask their oncologist or care team whether a clinical trial is worth exploring and who can help review it. The National Cancer Institute offers information about finding trials and questions to ask before joining one.

Questions to Ask About a Clinical Trial

  • Is there a clinical trial for my diagnosis and treatment history?
  • What would participation involve?
  • What are the possible benefits, risks and time commitments?
  • Would joining affect my other treatment options?
  • Can you help me understand the consent form?

A patient’s trust in research should come with clear expectations. An approach being studied is not necessarily proven to work or available outside a trial. If an article names a drug or describes trial results, those details should be checked against current sources and reviewed by a qualified clinician.

Managing Symptoms While Considering Treatment

Treatment decisions can take time, but support for symptoms can be part of care throughout that process. Patients should tell their care team about new or worsening symptoms. That could include pain, difficulty swallowing or eating, voice changes, fatigue or changes in breathing. The team can help assess what may be causing a symptom and what support is appropriate.

Make Symptom Conversations Specific

It may help to keep a short record of symptoms, when they happen and how they affect daily activities. For example, a patient might note whether swallowing is harder at certain times or whether pain is affecting sleep. These notes can make it easier to explain what has changed at an appointment.

Patients should contact their care team about symptoms that concern them, rather than trying to decide on their own what a symptom means. If a symptom is sudden or severe, they should follow the urgent-care instructions provided by their clinicians.

Senior man thinking about medical history

Ask About Supportive & Palliative Care

Supportive care can address the practical and emotional effects of cancer and its treatment. Depending on a person’s needs, the care team may connect them with help for nutrition, speech and swallowing, pain, dental care or emotional well-being. Palliative care which focuses on relief from symptoms and stress, can also be part of cancer care. Palliative care can be provided alongside treatment intended to control cancer.

Asking for this support is a way to make sure that symptoms and quality of life are part of the conversation. Patients should ask who coordinates supportive services and how to reach that person between appointments.

A Few Practical Steps That May Help

  • Write down symptoms and questions before appointments. Keeping a journal or log of how you feel could help.
  • Tell the care team when eating, speaking, sleeping or daily activities become harder.
  • Ask which supportive services are available.
  • Bring a caregiver or trusted person as support during appointments and to help keep track of what is covered in conversation with the care team.

A 30 Stories Perspective On Facing Recurrence

In his 30 Stories account, James describes an aggressive form of squamous cell carcinoma that returned just weeks after an earlier growth was removed. After surgery and additional treatment, he learned the cancer had spread to several parts of his body. He then had the opportunity to receive immunotherapy, which he says stopped the cancer’s spread and significantly reduced it.

James’s experience is his own and cannot predict what another person’s treatment will be like. However, his story does show how a care plan can change, and how support from family and clinicians can matter through each stage. He also speaks openly about living with a tracheostomy and finding hope in time with his family.

Questions to Bring to Your Next Appointment

When cancer returns, it can be hard to remember every question at the moment. Patients may want to choose a few questions that matter most to them and bring them to the next visit. The care team can help explain the findings, the options and what the next decision involves.

  • Where has the cancer returned or spread?
  • What do we know from my scans and other tests?
  • How does my previous treatment affect the options now?
  • Could additional testing help guide a decision?
  • What is the goal of each treatment option?
  • Is a clinical trial appropriate now or might it be worth discussing later?
  • Who can help me manage symptoms and daily needs?

Finding Hope in a Changing Treatment Landscape

A recurrence can change the path a person is expected to follow. It can also lead to a fresh review of the cancer, the person’s priorities and the available options. Research continues to explore new approaches, while clinicians can help patients understand what is established, what remains under study and what may be relevant to their case.

There is no single way to feel hopeful. For some people, hope may mean considering another treatment. For others, it may mean getting clearer answers, managing a difficult symptom or making a decision that reflects their priorities. Patients deserve clear information and support through each of those conversations.

Johnson and Johnson logo